Changeflow GovPing Healthcare & Life Sciences FDA Issues Emergency Use Authorization for F10 ...
Priority review Rule Added Final

FDA Issues Emergency Use Authorization for F10 Antiseptic Barrier Ointment for New World Screwworm

Favicon for www.fda.gov FDA CVM Veterinary Medicine Updates
Published
Detected
Email

Summary

The FDA issued an Emergency Use Authorization (EUA) on April 24, 2026, for F10 Antiseptic Barrier Ointment with Insecticide (benzalkonium chloride, polyhexanide and cypermethrin topical ointment) to prevent and treat New World screwworm infestations in cattle, horses, sheep, goats, deer, wild birds, pet birds, and captive wild, exotic, and zoo mammals. The product may not be used in domestic dogs and cats. Food safety requirements include a 30-day slaughter withdrawal period for cattle, goats, and sheep, and a 10-day milk discard time. The EUA remains effective until revoked or the HHS Secretary terminates the NWS public health emergency declaration. The product is sponsored by Health and Hygiene (Pty) Ltd of South Africa and is available over the counter.

“The FDA has concluded that based on the scientific evidence available, it is reasonable to believe that F10 Antiseptic Barrier Ointment with Insecticide may be effective in the prevention and treatment of NWS myiasis in cattle, horses, minor species of hoof stock (e.g., sheep, goats, deer), raptors and other wild birds, pet birds, and captive wild, exotic, and zoo mammals, and the known and potential benefits of the product outweigh its known and potential risks.”

FDA , verbatim from source
Why this matters

Livestock producers and animal health practitioners using F10 Antiseptic Barrier Ointment under this EUA must enforce the 30-day slaughter withdrawal for cattle, goats, and sheep and the 10-day milk discard period for dairy animals. Producers of veal from calves born to treated cows face a complete prohibition on processing for human consumption. Zoos, wildlife rehabilitators, and horse facilities treating exotic or wild species should document all treatments to demonstrate compliance with the EUA terms if audited.

AI-drafted from the source document, validated against GovPing's analyst note standards . For the primary regulatory language, read the source document .
Published by FDA on fda.gov . Detected, standardized, and enriched by GovPing. Review our methodology and editorial standards .

About this source

GovPing monitors FDA CVM Veterinary Medicine Updates for new healthcare & life sciences regulatory changes. Every update since tracking began is archived, classified, and available as free RSS or email alerts — 8 changes logged to date.

What changed

The FDA issued an Emergency Use Authorization for F10 Antiseptic Barrier Ointment with Insecticide, a previously unapproved animal drug now authorized for emergency use against New World screwworm infestations in multiple species including cattle, horses, small hoofstock, birds, and captive exotic mammals. The product may not be used in domestic dogs and cats. Food safety requirements apply: treated cattle, goats, and sheep cannot be slaughtered within 30 days of treatment, and milk from treated dairy animals cannot be used for human consumption within 10 days after treatment.

Affected parties include livestock producers, zoo operators, wildlife rehabilitators, horse owners, and pet bird owners who may now access this OTC product for screwworm prevention and treatment. Compliance with the labeled withdrawal periods and milk discard times is required when following the EUA terms. Pre-ruminating calves cannot be processed for veal if born to treated cows.

Archived snapshot

Apr 24, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.


April 24, 2026

Today, the U.S. Food and Drug Administration issued an Emergency Use Authorization (EUA) for F10 Antiseptic Barrier Ointment with Insecticide (benzalkonium chloride, polyhexanide and cypermethrin topical ointment) for the prevention and treatment of New World screwworm (NWS) infestations (myiasis).

The FDA has concluded that based on the scientific evidence available, it is reasonable to believe that F10 Antiseptic Barrier Ointment with Insecticide may be effective in the prevention and treatment of NWS myiasis in cattle, horses, minor species of hoof stock (e.g., sheep, goats, deer), raptors and other wild birds, pet birds, and captive wild, exotic, and zoo mammals, and the known and potential benefits of the product outweigh its known and potential risks. F10 Antiseptic Barrier Ointment with Insecticide may not be used in domestic dogs and cats.

Prior to this ointment formulation, the FDA authorized F10 Antiseptic Wound Spray with Insecticide on March 10, 2026.

The agency evaluated relevant human food safety information and concluded that the food products obtained from treated animals are safe for human consumption when the terms and conditions of use granted by the EUA are followed, including the withdrawal period and milk discard time.

Important food safety information:

F10 Antiseptic Barrier Ointment with Insecticide is available over the counter without a prescription. The FDA added F10 Antiseptic Barrier Ointment with Insecticide (Minor Species Index File (MIF) 900-011) to The Index of Legally Marketed Unapproved New Animal Drugs for Minor Species in 2015 for use as a topical antiseptic for surface wounds, to repel flies, and to treat infestations due to fly strike in raptors, pet birds, captive small mammals, captive reptiles, and captive exotic/zoo mammals. The product has not been through the FDA’s approval or conditional approval process.

This EUA will be effective until it is revoked or the HHS Secretary terminates the declaration that the potential public health emergency presented by NWS justifies the emergency use authorization of animal drugs for NWS.

F10 Antiseptic Barrier Ointment with Insecticide is sponsored by Health and Hygiene (Pty) Ltd, based in South Africa.

Additional Information

04/24/2026

  • Regulated Product(s)

    • Animal & Veterinary

Get daily alerts for FDA CVM Veterinary Medicine Updates

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from FDA.

What's AI-generated?

The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.

Last updated

Classification

Agency
FDA
Published
April 24th, 2026
Instrument
Rule
Branch
Executive
Legal weight
Binding
Stage
Final
Change scope
Substantive

Who this affects

Applies to
Consumers Healthcare providers Manufacturers
Industry sector
3254 Pharmaceutical Manufacturing
Activity scope
Emergency use authorization Veterinary drug distribution Livestock treatment
Geographic scope
United States US

Taxonomy

Primary area
Animal & Veterinary
Operational domain
Clinical Operations
Topics
Pharmaceuticals Public Health

Get alerts for this source

We'll email you when FDA CVM Veterinary Medicine Updates publishes new changes.

Free. Unsubscribe anytime.

You're subscribed!